UniSa - IRIS Institutional Research Information System

ERRO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.338
NA - Nord America 6.648
EU - Europa 2.685
SA - Sud America 1.247
AF - Africa 85
OC - Oceania 66
Continente sconosciuto - Info sul continente non disponibili 5
Totale 25.074
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 11.368
US - Stati Uniti d'America 6.514
BR - Brasile 1.029
SG - Singapore 1.027
IT - Italia 704
CN - Cina 665
VN - Vietnam 515
RU - Federazione Russa 510
UA - Ucraina 363
IE - Irlanda 309
TR - Turchia 279
DE - Germania 241
KR - Corea 226
SE - Svezia 182
GB - Regno Unito 90
AR - Argentina 81
FI - Finlandia 76
CA - Canada 65
IN - India 62
ID - Indonesia 48
EC - Ecuador 44
EE - Estonia 37
AU - Australia 35
MX - Messico 35
NL - Olanda 34
BD - Bangladesh 33
NZ - Nuova Zelanda 28
AT - Austria 26
CO - Colombia 25
ZA - Sudafrica 24
IQ - Iraq 23
PL - Polonia 23
PY - Paraguay 21
JP - Giappone 18
CZ - Repubblica Ceca 16
ES - Italia 15
UZ - Uzbekistan 13
VE - Venezuela 13
FR - Francia 12
UY - Uruguay 12
MA - Marocco 11
PE - Perù 9
CL - Cile 8
DO - Repubblica Dominicana 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BE - Belgio 6
IR - Iran 6
JM - Giamaica 6
JO - Giordania 6
TN - Tunisia 6
BO - Bolivia 5
GR - Grecia 5
LT - Lituania 5
MD - Moldavia 5
NP - Nepal 5
PA - Panama 5
PK - Pakistan 5
IL - Israele 4
KW - Kuwait 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
ET - Etiopia 3
HU - Ungheria 3
NO - Norvegia 3
SO - Somalia 3
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
ME - Montenegro 2
NC - Nuova Caledonia 2
NI - Nicaragua 2
RS - Serbia 2
RW - Ruanda 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
Totale 25.048
Salva come PNG Salva come JPEG
Città #
Hong Kong 11.361
Ann Arbor 1.219
Princeton 848
Dallas 655
Chandler 538
Wilmington 494
Jacksonville 427
Singapore 381
Dublin 301
Izmir 265
Ashburn 230
Woodbridge 216
Houston 190
Salerno 186
Dong Ket 162
Moscow 153
Ho Chi Minh City 145
Andover 127
Beijing 122
Pellezzano 121
Nanjing 115
Naples 98
São Paulo 83
Hanoi 71
Boardman 69
Norwalk 69
Fairfield 62
Los Angeles 55
Munich 53
Düsseldorf 44
Shenyang 43
The Dalles 42
Nuremberg 41
Tallinn 37
Hebei 36
Nanchang 34
Pune 34
Rio de Janeiro 32
Brasília 30
Dearborn 29
Changsha 28
Council Bluffs 28
Seoul 28
Columbus 27
Mestre 27
West Jordan 27
Jiaxing 26
Belo Horizonte 24
San Diego 23
New York 22
Redwood City 22
Curitiba 21
London 21
Seattle 21
Turku 20
Brooklyn 18
Haiphong 18
Rome 18
Warsaw 18
Fortaleza 17
Guarulhos 17
Washington 17
San Francisco 16
Santa Clara 16
Boston 15
Cambridge 15
Guayaquil 15
Johannesburg 15
Stockholm 15
Sydney 15
Amsterdam 14
Lecce 14
Montreal 14
Quito 14
Tianjin 14
Auckland 13
Guangzhou 13
Tokyo 13
Da Nang 12
Falls Church 12
Salvador 12
Tashkent 12
Baghdad 11
Milan 11
Piracicaba 11
Porto Alegre 11
Thái Bình 11
Toronto 11
Uberlândia 11
Brno 10
Chicago 10
Fort Worth 10
Joinville 10
Lappeenranta 10
Orange 10
Campinas 9
Ribeirão Preto 9
Anápolis 8
Carapicuíba 8
Caxias do Sul 8
Totale 20.164
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.156
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 921
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 909
Sex Differences in Parkinson’s Disease: From Bench to Bedside 621
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 514
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 511
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 476
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 473
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 429
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 428
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 426
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 425
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 359
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 357
Non-invasive brain stimulation for dystonia: therapeutic implications 340
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 328
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 308
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. 287
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 279
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 275
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 255
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 234
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 227
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 201
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 197
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 190
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 178
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 171
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 171
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 157
ADCY5 mutations are another cause of benign hereditary chorea 152
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 141
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 135
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 133
Increased bilirubin levels in de novo Parkinson's disease 123
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 123
Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (Conversion Disorder): A pilot, single-blinded, randomized study 122
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 119
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 117
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 117
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 117
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 116
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 114
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 111
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 109
Quitting smoking: An early non-motor feature of Parkinson's disease? 109
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 109
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 108
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 108
The Motor Syndrome of Parkinson's Disease 108
Cerebellar and brainstem functional abnormalities in patients with primary orthostatic tremor 107
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 105
Abnormal eating behaviors in progressive supranuclear palsy. 102
Gender and non motor fluctuations in Parkinson's disease: A prospective study 100
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 100
Machine learning can predict mild cognitive impairment in Parkinson's disease 98
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 98
Malabsorption is uncommon in restless legs syndrome. 97
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 97
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 97
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 95
On the relationship between side of onset and cognition in Parkinson disease 94
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 90
Early MRI findings in acquired hepatocerebral degeneration. 89
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 89
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 88
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 87
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 86
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 86
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 85
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 85
A novel therapeutic approach for synucleinopathies 85
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 84
Uric acid relates to dopamine transporter availability in Parkinson's disease. 83
Non-motor correlates of smoking habits in de novo Parkinson's disease 82
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 81
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 81
Impact of COVID-19 on neurological patients attending a botulinum toxin service 80
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 79
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 77
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 77
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 77
Orthostatic myoclonus associated with Caspr2 antibodies 77
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor 77
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 76
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 76
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 75
What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies 75
Genetics of Movement Disorders and the Practicing Clinician; Who and What to Test for? 74
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 72
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 71
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 71
“Atypical” atypical parkinsonism: Critical appraisal of a cohort 71
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 71
Essential tremor plus rest tremor: current concepts and controversies 70
Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study. 70
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 70
Restless legs syndrome is a common feature of adult celiac disease 70
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 69
Totale 18.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021575 0 0 0 11 77 60 70 6 58 2 81 210
2021/20221.275 5 1 5 9 24 8 17 37 146 164 216 643
2022/20231.556 242 102 73 141 171 371 18 129 202 8 66 33
2023/20241.005 45 132 57 61 46 120 37 77 49 66 55 260
2024/20252.997 84 40 50 121 116 342 372 261 452 422 371 366
2025/202613.926 3.066 5.569 4.716 575 0 0 0 0 0 0 0 0
Totale 25.656